Quintiles Transitional Holdings Inc. (Q) Shares Bought by Tillar Wenstrup Advisors LLC
Tillar Wenstrup Advisors LLC increased its position in Quintiles Transitional Holdings Inc. (NYSE:Q) by 7.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,651 shares of the medical research company’s stock after buying an additional 1,577 shares during the period. Tillar Wenstrup Advisors LLC’s holdings in Quintiles Transitional Holdings were worth $1,938,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. John G Ullman & Associates Inc. bought a new stake in shares of Quintiles Transitional Holdings during the first quarter worth approximately $290,000. ProShare Advisors LLC bought a new stake in shares of Quintiles Transitional Holdings during the first quarter worth approximately $229,000. Candriam Luxembourg S.C.A. raised its stake in shares of Quintiles Transitional Holdings by 31.5% in the first quarter. Candriam Luxembourg S.C.A. now owns 22,313 shares of the medical research company’s stock worth $1,797,000 after buying an additional 5,340 shares during the last quarter. State of Alaska Department of Revenue bought a new stake in shares of Quintiles Transitional Holdings during the first quarter worth approximately $244,000. Finally, DnB Asset Management AS raised its stake in shares of Quintiles Transitional Holdings by 3.3% in the first quarter. DnB Asset Management AS now owns 89,621 shares of the medical research company’s stock worth $7,217,000 after buying an additional 2,900 shares during the last quarter. Institutional investors and hedge funds own 91.83% of the company’s stock.
Quintiles Transitional Holdings (NYSE:Q) last released its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 15.68%. The firm had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.96 billion. During the same quarter in the prior year, the company posted $0.93 earnings per share. The business’s revenue was up 68.7% on a year-over-year basis.
Quintiles Transitional Holdings announced that its Board of Directors has approved a stock buyback plan on Wednesday, May 24th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the medical research company to buy up to 5.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.
WARNING: “Quintiles Transitional Holdings Inc. (Q) Shares Bought by Tillar Wenstrup Advisors LLC” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2017/08/07/quintiles-transitional-holdings-inc-q-shares-bought-by-tillar-wenstrup-advisors-llc.html.
A number of equities research analysts recently commented on the stock. Zacks Investment Research upgraded shares of Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a report on Thursday, July 27th. William Blair upgraded shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $70.10 to $93.42 in a report on Friday. Stifel Nicolaus restated a “hold” rating and set a $92.00 price objective on shares of Quintiles Transitional Holdings in a report on Friday. Barclays PLC raised their price objective on shares of Quintiles Transitional Holdings from $98.00 to $100.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Jefferies Group LLC restated a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a report on Friday. Eleven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $89.88.
In other news, major shareholder Cpp Investment Board Private H sold 7,131,165 shares of the stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $84.01, for a total value of $599,089,171.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director John G. Danhakl sold 761,143 shares of the stock in a transaction dated Tuesday, May 30th. The shares were sold at an average price of $84.01, for a total transaction of $63,943,623.43. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,758,400 shares of company stock worth $735,783,985. Corporate insiders own 6.40% of the company’s stock.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding Q? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quintiles Transitional Holdings Inc. (NYSE:Q).
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.